IndiaTickerLatest filing: Kilitch Drugs India Ltd - 524500 - Board Meeting Outcome for Outcome Of Board Meeting
ObservedCompany dossier
Kilitch Drugs
NSE:KILITCH · ISIN INE729D01010
- Close
- Unavailable Date unavailable
- Daily change
- N/A Exchange close
- Evidence state
- Building 0/0 checks
Kilitch Drugs
Overview
Evidence state
Coverage in progressCompany record at a glance
Latest reported period: 31 Dec 2024 · revenue ₹56.2 Cr · PAT ₹5.6 Cr.
Exchange XBRLLatest ownership: promoter group 63.77% and public 36.23% as of 30 Jun 2026.
Exchange XBRLMaterial events
Open timeline →What changed recently
Observed
Source filing Kilitch Drugs India Ltd - 524500 - Board Meeting Outcome for Outcome Of Board Meeting
BSE · exchange filing
Observed
Source filing Outcome of Board Meeting - Kilitch Drugs (India) Limited
NSE · financial results
Observed
Source filing Certificate under SEBI (Depositories and Participants) Regulations, 2018 - Kilitch Drugs (India) Limited
NSE · exchange filing
Observed
Source filing Kilitch Drugs India Ltd - 524500 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
BSE · exchange filing
Reported financials
Full financials →31 Dec 2024
- Revenue from operations
- ₹56.2 Cr
- Profit after tax
- ₹5.6 Cr
- EPS
- ₹3.71
Observed NSE structured filing · Consolidated
Ownership
Full shareholding →30 Jun 2026
- Promoter group
- 63.77%
- Public
- 36.23%
- Employee trust
- 0.00%
Observed NSE shareholding XBRL